Alger Health Sciences Fund Class C (AHSCX) is a Health fund with $65.99 Million in assets. The fund allocates 21.66% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is UnitedHealth Group Inc at 8.06% of total assets. This is followed by Amgen Inc (4.08%) and AstraZeneca PLC (None).
| Name | Weight | Owned | Change |
|---|---|---|---|
| UnitedHealth Group Inc | 8.06% | - | - |
| Amgen Inc | 4.08% | - | - |
| AstraZeneca PLC | None | - | - |
| AbbVie Inc | 2.83% | - | - |
| McKesson Corp | 3.47% | - | - |
| Regeneron Pharmaceuticals Inc | None | - | - |
| Eli Lilly Co | 3.22% | - | - |
| Merck Co Inc | None | - | - |
| Vertex Pharmaceuticals Inc | None | - | - |
| ICON PLC | None | - | - |
| Intuitive Surgical Inc | 5.06% | - | - |
| Boston Scientific Corp | 3.05% | - | - |
| IMPULSE DYNAMICS IRELAND | 4.34% | - | - |
| Illumina Inc | 4.30% | - | - |
| Welltower Inc | 4.32% | - | - |
| Bristol-Myers Squibb Co | 3.66% | - | - |
| Stryker Corp | 4.03% | - | - |
| Sandoz Group AG | 4.63% | - | - |
| Masimo Corp | 4.04% | - | - |
| Cardinal Health Inc | 4.04% | - | - |
| Abbott Laboratories | 5.20% | - | - |
| Waystar Holding Corp | 4.93% | - | - |
| Dreyfus Treasury Obligations Cash Management Fund | 4.44% | - | - |
| Royalty Pharma PLC | 4.03% | - | - |
| American Healthcare REIT Inc | 3.38% | - | - |
| Gilead Sciences Inc | 3.10% | - | - |
| CVS Health Corp | 4.81% | - | - |
| Repligen Corp | 4.01% | - | - |
| Nektar Therapeutics | 3.34% | - | - |
| Cidara Therapeutics Inc | 2.87% | - | - |